section name header

Information

(1) Drugs—cancer chemotherapeutic agents are most common cause, also phenytoin, carbamazepine, indomethacin, chloramphenicol, penicillins, sulfonamides, cephalosporins, propylthiouracil, phenothiazines, captopril, methyldopa, procainamide, chlorpropamide, thiazides, cimetidine, allopurinol, colchicine, ethanol, penicillamine, and immunosuppressive agents; (2) infections—viral (e.g., influenza, hepatitis, infectious mononucleosis, HIV), bacterial (e.g., typhoid fever, miliary tuberculosis, fulminant sepsis), malaria; (3) nutritional—B12, folate deficiencies; (4) benign—benign ethnic neutropenia (BEN) seen in up to 25% of blacks, no associated risk of infection; (5) hematologic diseases—cyclic neutropenia (q21d, with recurrent infections common), leukemia, myelodysplasia (preleukemia), aplastic anemia, bone marrow infiltration (uncommon cause), Chédiak-Higashi syndrome; (6) hypersplenism—e.g., Felty's syndrome, congestive splenomegaly, Gaucher's disease; (7) autoimmune diseases—idiopathic, SLE, lymphoma (may see positive antineutrophil antibodies); (8) genetics—inheritance of an allele of the Duffy antigen receptor for cytokines (DARC) can be associated with constitutive neutropenia that is not associated with predilection to infection; more common in African Americans.

Treatment: Thrombotic Disorders

In addition to usual sources of infection, consider paranasal sinuses, oral cavity (including teeth and gums), anorectal region; empirical therapy with broad-spectrum antibiotics (e.g., ceftazidime) is indicated after blood and other appropriate cultures are obtained. Prolonged febrile neutropenia (>7 days) leads to increased risk of disseminated fungal infections; requires addition of antifungal chemotherapy (e.g., amphotericin B). The duration of chemotherapy-induced neutropenia may be shortened by a few days by treatment with the cytokines GM-CSF or G-CSF.

Outline

Section 6. Hematology and Oncology